nodes	percent_of_prediction	percent_of_DWPC	metapath
Desogestrel—Depressed mood—Brinzolamide—glaucoma	0.0199	0.0219	CcSEcCtD
Desogestrel—Erythema nodosum—Pilocarpine—glaucoma	0.0197	0.0218	CcSEcCtD
Desogestrel—Hirsutism—Bimatoprost—glaucoma	0.0184	0.0203	CcSEcCtD
Desogestrel—Hypertension—Dipivefrin—glaucoma	0.0114	0.0126	CcSEcCtD
Desogestrel—Cataract—Bimatoprost—glaucoma	0.0112	0.0124	CcSEcCtD
Desogestrel—Breast enlargement—Clonidine—glaucoma	0.0105	0.0116	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.0104	0.111	CbGpPWpGaD
Desogestrel—Cataract—Brimonidine—glaucoma	0.00994	0.011	CcSEcCtD
Desogestrel—Breast pain—Pilocarpine—glaucoma	0.00979	0.0108	CcSEcCtD
Desogestrel—Cataract—Travoprost—glaucoma	0.00945	0.0104	CcSEcCtD
Desogestrel—Cataract—Pilocarpine—glaucoma	0.00897	0.0099	CcSEcCtD
Desogestrel—Weight decreased—Diclofenamide—glaucoma	0.00878	0.00969	CcSEcCtD
Desogestrel—Libido decreased—Apraclonidine—glaucoma	0.00863	0.00952	CcSEcCtD
Desogestrel—Vomiting—Physostigmine—glaucoma	0.00806	0.0089	CcSEcCtD
Desogestrel—Hypersensitivity—Dipivefrin—glaucoma	0.00794	0.00877	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Apraclonidine—glaucoma	0.00794	0.00876	CcSEcCtD
Desogestrel—Nausea—Physostigmine—glaucoma	0.00753	0.00831	CcSEcCtD
Desogestrel—Libido decreased—Dorzolamide—glaucoma	0.00707	0.00781	CcSEcCtD
Desogestrel—Erythema multiforme—Levobunolol—glaucoma	0.00706	0.00779	CcSEcCtD
Desogestrel—Libido decreased—Brinzolamide—glaucoma	0.00695	0.00768	CcSEcCtD
Desogestrel—Breast pain—Betaxolol—glaucoma	0.0068	0.00751	CcSEcCtD
Desogestrel—Erythema multiforme—Methazolamide—glaucoma	0.00676	0.00746	CcSEcCtD
Desogestrel—Alopecia—Levobunolol—glaucoma	0.0066	0.00728	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Dorzolamide—glaucoma	0.00651	0.00718	CcSEcCtD
Desogestrel—Affect lability—Dorzolamide—glaucoma	0.00646	0.00713	CcSEcCtD
Desogestrel—Hypertension—Metipranolol—glaucoma	0.00641	0.00708	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Brinzolamide—glaucoma	0.0064	0.00706	CcSEcCtD
Desogestrel—Cataract—Betaxolol—glaucoma	0.00624	0.00688	CcSEcCtD
Desogestrel—Mood swings—Dorzolamide—glaucoma	0.00621	0.00686	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.00612	0.065	CbGpPWpGaD
Desogestrel—Migraine—Pilocarpine—glaucoma	0.0061	0.00673	CcSEcCtD
Desogestrel—Affect lability—Pilocarpine—glaucoma	0.0061	0.00673	CcSEcCtD
Desogestrel—Mood swings—Pilocarpine—glaucoma	0.00587	0.00648	CcSEcCtD
Desogestrel—Breast disorder—Brinzolamide—glaucoma	0.00583	0.00643	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.00571	0.0607	CbGpPWpGaD
Desogestrel—Libido decreased—Clonidine—glaucoma	0.00534	0.00589	CcSEcCtD
Desogestrel—Eye disorder—Apraclonidine—glaucoma	0.00517	0.00571	CcSEcCtD
Desogestrel—Weight decreased—Dorzolamide—glaucoma	0.00513	0.00566	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.0051	0.00562	CcSEcCtD
Desogestrel—Cataract—Timolol—glaucoma	0.00509	0.00562	CcSEcCtD
Desogestrel—Eye disorder—Bimatoprost—glaucoma	0.00501	0.00554	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Clonidine—glaucoma	0.00491	0.00542	CcSEcCtD
Desogestrel—Mental disorder—Apraclonidine—glaucoma	0.00485	0.00535	CcSEcCtD
Desogestrel—Nervous system disorder—Latanoprost—glaucoma	0.00482	0.00532	CcSEcCtD
Desogestrel—Skin disorder—Latanoprost—glaucoma	0.00478	0.00527	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00476	0.00526	CcSEcCtD
Desogestrel—Erythema multiforme—Acetazolamide—glaucoma	0.00468	0.00517	CcSEcCtD
Desogestrel—Libido decreased—Betaxolol—glaucoma	0.00465	0.00513	CcSEcCtD
Desogestrel—Breast disorder—Clonidine—glaucoma	0.00447	0.00494	CcSEcCtD
Desogestrel—Hypersensitivity—Metipranolol—glaucoma	0.00446	0.00493	CcSEcCtD
Desogestrel—Eye disorder—Brimonidine—glaucoma	0.00444	0.0049	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Methazolamide—glaucoma	0.00439	0.00484	CcSEcCtD
Desogestrel—Immune system disorder—Brimonidine—glaucoma	0.00429	0.00474	CcSEcCtD
Desogestrel—Erythema multiforme—Dorzolamide—glaucoma	0.00429	0.00474	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Betaxolol—glaucoma	0.00428	0.00472	CcSEcCtD
Desogestrel—Abdominal pain—Carbachol—glaucoma	0.00426	0.0047	CcSEcCtD
Desogestrel—ESR1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00426	0.0453	CbGpPWpGaD
Desogestrel—Affect lability—Betaxolol—glaucoma	0.00424	0.00468	CcSEcCtD
Desogestrel—Eye disorder—Travoprost—glaucoma	0.00422	0.00466	CcSEcCtD
Desogestrel—Urticaria—Levobunolol—glaucoma	0.00421	0.00465	CcSEcCtD
Desogestrel—Eye disorder—Brinzolamide—glaucoma	0.00417	0.0046	CcSEcCtD
Desogestrel—Mental disorder—Brimonidine—glaucoma	0.00416	0.0046	CcSEcCtD
Desogestrel—Hypersensitivity—Carteolol—glaucoma	0.00414	0.00456	CcSEcCtD
Desogestrel—Mood swings—Betaxolol—glaucoma	0.00408	0.00451	CcSEcCtD
Desogestrel—Immune system disorder—Travoprost—glaucoma	0.00408	0.0045	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00407	0.0045	CcSEcCtD
Desogestrel—Urticaria—Methazolamide—glaucoma	0.00404	0.00446	CcSEcCtD
Desogestrel—Hypertension—Bimatoprost—glaucoma	0.00403	0.00445	CcSEcCtD
Desogestrel—Immune system disorder—Brinzolamide—glaucoma	0.00403	0.00445	CcSEcCtD
Desogestrel—Alopecia—Dorzolamide—glaucoma	0.00401	0.00443	CcSEcCtD
Desogestrel—Eye disorder—Pilocarpine—glaucoma	0.00401	0.00442	CcSEcCtD
Desogestrel—Mental disorder—Travoprost—glaucoma	0.00396	0.00437	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00395	0.00436	CcSEcCtD
Desogestrel—Alopecia—Brinzolamide—glaucoma	0.00394	0.00435	CcSEcCtD
Desogestrel—Mental disorder—Brinzolamide—glaucoma	0.00391	0.00431	CcSEcCtD
Desogestrel—Hypersensitivity—Levobunolol—glaucoma	0.00391	0.00431	CcSEcCtD
Desogestrel—Breast disorder—Betaxolol—glaucoma	0.00389	0.0043	CcSEcCtD
Desogestrel—Weight increased—Clonidine—glaucoma	0.00389	0.0043	CcSEcCtD
Desogestrel—Malnutrition—Brinzolamide—glaucoma	0.00388	0.00429	CcSEcCtD
Desogestrel—Nervous system disorder—Apraclonidine—glaucoma	0.00386	0.00426	CcSEcCtD
Desogestrel—Rash—Metipranolol—glaucoma	0.00382	0.00422	CcSEcCtD
Desogestrel—Skin disorder—Apraclonidine—glaucoma	0.00382	0.00422	CcSEcCtD
Desogestrel—Dermatitis—Metipranolol—glaucoma	0.00382	0.00421	CcSEcCtD
Desogestrel—Libido decreased—Timolol—glaucoma	0.0038	0.00419	CcSEcCtD
Desogestrel—Headache—Metipranolol—glaucoma	0.0038	0.00419	CcSEcCtD
Desogestrel—Alopecia—Pilocarpine—glaucoma	0.00379	0.00418	CcSEcCtD
Desogestrel—Nervous system disorder—Bimatoprost—glaucoma	0.00374	0.00413	CcSEcCtD
Desogestrel—Skin disorder—Bimatoprost—glaucoma	0.0037	0.00409	CcSEcCtD
Desogestrel—Diarrhoea—Carbachol—glaucoma	0.00369	0.00407	CcSEcCtD
Desogestrel—Diarrhoea—Levobunolol—glaucoma	0.00363	0.00401	CcSEcCtD
Desogestrel—Nausea—Metipranolol—glaucoma	0.0036	0.00397	CcSEcCtD
Desogestrel—Hypertension—Brimonidine—glaucoma	0.00357	0.00394	CcSEcCtD
Desogestrel—Headache—Carteolol—glaucoma	0.00352	0.00388	CcSEcCtD
Desogestrel—Vomiting—Diclofenamide—glaucoma	0.00351	0.00387	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.0035	0.00386	CcSEcCtD
Desogestrel—Disturbance in sexual arousal—Timolol—glaucoma	0.00349	0.00386	CcSEcCtD
Desogestrel—Rash—Diclofenamide—glaucoma	0.00348	0.00384	CcSEcCtD
Desogestrel—Diarrhoea—Methazolamide—glaucoma	0.00348	0.00384	CcSEcCtD
Desogestrel—Affect lability—Timolol—glaucoma	0.00347	0.00382	CcSEcCtD
Desogestrel—Headache—Diclofenamide—glaucoma	0.00346	0.00382	CcSEcCtD
Desogestrel—Vomiting—Carbachol—glaucoma	0.00342	0.00378	CcSEcCtD
Desogestrel—Hypertension—Dorzolamide—glaucoma	0.00341	0.00376	CcSEcCtD
Desogestrel—Rash—Carbachol—glaucoma	0.0034	0.00375	CcSEcCtD
Desogestrel—Hypertension—Travoprost—glaucoma	0.0034	0.00375	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00339	0.00375	CcSEcCtD
Desogestrel—Dermatitis—Carbachol—glaucoma	0.00339	0.00375	CcSEcCtD
Desogestrel—Weight increased—Betaxolol—glaucoma	0.00339	0.00374	CcSEcCtD
Desogestrel—Headache—Carbachol—glaucoma	0.00337	0.00372	CcSEcCtD
Desogestrel—Weight decreased—Betaxolol—glaucoma	0.00337	0.00372	CcSEcCtD
Desogestrel—Hypertension—Brinzolamide—glaucoma	0.00335	0.0037	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.00335	0.0356	CbGpPWpGaD
Desogestrel—Mood swings—Timolol—glaucoma	0.00333	0.00368	CcSEcCtD
Desogestrel—Nausea—Carteolol—glaucoma	0.00333	0.00368	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00333	0.00367	CcSEcCtD
Desogestrel—Headache—Levobunolol—glaucoma	0.00332	0.00367	CcSEcCtD
Desogestrel—PGR—Ovarian Infertility Genes—CCND2—glaucoma	0.00332	0.0353	CbGpPWpGaD
Desogestrel—Nervous system disorder—Brimonidine—glaucoma	0.00331	0.00365	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00329	0.00363	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00328	0.00362	CcSEcCtD
Desogestrel—Skin disorder—Brimonidine—glaucoma	0.00328	0.00362	CcSEcCtD
Desogestrel—Nausea—Diclofenamide—glaucoma	0.00328	0.00362	CcSEcCtD
Desogestrel—Vomiting—Methazolamide—glaucoma	0.00323	0.00357	CcSEcCtD
Desogestrel—Hypertension—Pilocarpine—glaucoma	0.00322	0.00356	CcSEcCtD
Desogestrel—Gastrointestinal pain—Apraclonidine—glaucoma	0.00322	0.00355	CcSEcCtD
Desogestrel—Rash—Methazolamide—glaucoma	0.0032	0.00354	CcSEcCtD
Desogestrel—Dermatitis—Methazolamide—glaucoma	0.0032	0.00353	CcSEcCtD
Desogestrel—Eye disorder—Clonidine—glaucoma	0.0032	0.00353	CcSEcCtD
Desogestrel—Nausea—Carbachol—glaucoma	0.0032	0.00353	CcSEcCtD
Desogestrel—Headache—Methazolamide—glaucoma	0.00318	0.00351	CcSEcCtD
Desogestrel—Breast disorder—Timolol—glaucoma	0.00318	0.00351	CcSEcCtD
Desogestrel—Nausea—Levobunolol—glaucoma	0.00315	0.00348	CcSEcCtD
Desogestrel—Nervous system disorder—Travoprost—glaucoma	0.00315	0.00347	CcSEcCtD
Desogestrel—Skin disorder—Travoprost—glaucoma	0.00312	0.00344	CcSEcCtD
Desogestrel—ESR1—LKB1 signaling events—RPTOR—glaucoma	0.00311	0.0331	CbGpPWpGaD
Desogestrel—Abdominal pain—Apraclonidine—glaucoma	0.00311	0.00343	CcSEcCtD
Desogestrel—Nervous system disorder—Brinzolamide—glaucoma	0.00311	0.00343	CcSEcCtD
Desogestrel—Rash—Latanoprost—glaucoma	0.0031	0.00342	CcSEcCtD
Desogestrel—Dermatitis—Latanoprost—glaucoma	0.0031	0.00342	CcSEcCtD
Desogestrel—Headache—Latanoprost—glaucoma	0.00308	0.0034	CcSEcCtD
Desogestrel—Skin disorder—Brinzolamide—glaucoma	0.00308	0.0034	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00304	0.00335	CcSEcCtD
Desogestrel—Alopecia—Clonidine—glaucoma	0.00303	0.00334	CcSEcCtD
Desogestrel—Nausea—Methazolamide—glaucoma	0.00302	0.00333	CcSEcCtD
Desogestrel—Mental disorder—Clonidine—glaucoma	0.003	0.00331	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Brimonidine—glaucoma	0.00291	0.00322	CcSEcCtD
Desogestrel—Hypersensitivity—Apraclonidine—glaucoma	0.0029	0.0032	CcSEcCtD
Desogestrel—ESR1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.00283	0.0301	CbGpPWpGaD
Desogestrel—Urticaria—Acetazolamide—glaucoma	0.00279	0.00308	CcSEcCtD
Desogestrel—Eye disorder—Betaxolol—glaucoma	0.00279	0.00308	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Travoprost—glaucoma	0.00277	0.00306	CcSEcCtD
Desogestrel—Weight decreased—Timolol—glaucoma	0.00275	0.00304	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00274	0.00302	CcSEcCtD
Desogestrel—Immune system disorder—Betaxolol—glaucoma	0.00269	0.00297	CcSEcCtD
Desogestrel—Diarrhoea—Apraclonidine—glaucoma	0.00269	0.00297	CcSEcCtD
Desogestrel—Gastrointestinal pain—Dorzolamide—glaucoma	0.00264	0.00291	CcSEcCtD
Desogestrel—Alopecia—Betaxolol—glaucoma	0.00263	0.00291	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00263	0.0029	CcSEcCtD
Desogestrel—Gastrointestinal pain—Travoprost—glaucoma	0.00262	0.0029	CcSEcCtD
Desogestrel—Mental disorder—Betaxolol—glaucoma	0.00261	0.00288	CcSEcCtD
Desogestrel—Malnutrition—Betaxolol—glaucoma	0.0026	0.00286	CcSEcCtD
Desogestrel—Urticaria—Dorzolamide—glaucoma	0.00256	0.00283	CcSEcCtD
Desogestrel—Abdominal pain—Dorzolamide—glaucoma	0.00255	0.00281	CcSEcCtD
Desogestrel—Abdominal pain—Travoprost—glaucoma	0.00254	0.0028	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00252	0.00278	CcSEcCtD
Desogestrel—Urticaria—Brinzolamide—glaucoma	0.00252	0.00278	CcSEcCtD
Desogestrel—Vomiting—Apraclonidine—glaucoma	0.0025	0.00276	CcSEcCtD
Desogestrel—Gastrointestinal pain—Pilocarpine—glaucoma	0.00249	0.00275	CcSEcCtD
Desogestrel—Hypersensitivity—Brimonidine—glaucoma	0.00249	0.00275	CcSEcCtD
Desogestrel—Dermatitis—Apraclonidine—glaucoma	0.00248	0.00273	CcSEcCtD
Desogestrel—Headache—Apraclonidine—glaucoma	0.00246	0.00272	CcSEcCtD
Desogestrel—Abdominal pain—Pilocarpine—glaucoma	0.00241	0.00266	CcSEcCtD
Desogestrel—Diarrhoea—Acetazolamide—glaucoma	0.00241	0.00266	CcSEcCtD
Desogestrel—Rash—Bimatoprost—glaucoma	0.0024	0.00265	CcSEcCtD
Desogestrel—Dermatitis—Bimatoprost—glaucoma	0.0024	0.00265	CcSEcCtD
Desogestrel—Headache—Bimatoprost—glaucoma	0.00239	0.00264	CcSEcCtD
Desogestrel—Nervous system disorder—Clonidine—glaucoma	0.00239	0.00263	CcSEcCtD
Desogestrel—Hypersensitivity—Dorzolamide—glaucoma	0.00238	0.00262	CcSEcCtD
Desogestrel—Hypersensitivity—Travoprost—glaucoma	0.00237	0.00261	CcSEcCtD
Desogestrel—Skin disorder—Clonidine—glaucoma	0.00236	0.00261	CcSEcCtD
Desogestrel—Nausea—Apraclonidine—glaucoma	0.00234	0.00258	CcSEcCtD
Desogestrel—Hypersensitivity—Brinzolamide—glaucoma	0.00234	0.00258	CcSEcCtD
Desogestrel—Eye disorder—Timolol—glaucoma	0.00228	0.00251	CcSEcCtD
Desogestrel—PGR—Nuclear Receptors—NR3C1—glaucoma	0.00227	0.0242	CbGpPWpGaD
Desogestrel—Nausea—Bimatoprost—glaucoma	0.00226	0.0025	CcSEcCtD
Desogestrel—Hypersensitivity—Pilocarpine—glaucoma	0.00224	0.00248	CcSEcCtD
Desogestrel—Vomiting—Acetazolamide—glaucoma	0.00224	0.00247	CcSEcCtD
Desogestrel—Diarrhoea—Dorzolamide—glaucoma	0.00221	0.00243	CcSEcCtD
Desogestrel—Headache—Acetazolamide—glaucoma	0.0022	0.00243	CcSEcCtD
Desogestrel—Immune system disorder—Timolol—glaucoma	0.0022	0.00243	CcSEcCtD
Desogestrel—Diarrhoea—Travoprost—glaucoma	0.0022	0.00242	CcSEcCtD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00219	0.00242	CcSEcCtD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00217	0.0231	CbGpPWpGaD
Desogestrel—Diarrhoea—Brinzolamide—glaucoma	0.00217	0.00239	CcSEcCtD
Desogestrel—Alopecia—Timolol—glaucoma	0.00215	0.00238	CcSEcCtD
Desogestrel—Mental disorder—Timolol—glaucoma	0.00213	0.00236	CcSEcCtD
Desogestrel—Rash—Brimonidine—glaucoma	0.00213	0.00235	CcSEcCtD
Desogestrel—Dermatitis—Brimonidine—glaucoma	0.00213	0.00235	CcSEcCtD
Desogestrel—Malnutrition—Timolol—glaucoma	0.00212	0.00234	CcSEcCtD
Desogestrel—Headache—Brimonidine—glaucoma	0.00211	0.00233	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Clonidine—glaucoma	0.0021	0.00232	CcSEcCtD
Desogestrel—Nausea—Acetazolamide—glaucoma	0.00209	0.00231	CcSEcCtD
Desogestrel—Diarrhoea—Pilocarpine—glaucoma	0.00208	0.0023	CcSEcCtD
Desogestrel—Nervous system disorder—Betaxolol—glaucoma	0.00208	0.00229	CcSEcCtD
Desogestrel—Skin disorder—Betaxolol—glaucoma	0.00206	0.00227	CcSEcCtD
Desogestrel—Vomiting—Dorzolamide—glaucoma	0.00205	0.00226	CcSEcCtD
Desogestrel—Rash—Dorzolamide—glaucoma	0.00203	0.00224	CcSEcCtD
Desogestrel—Dermatitis—Dorzolamide—glaucoma	0.00203	0.00224	CcSEcCtD
Desogestrel—Rash—Travoprost—glaucoma	0.00202	0.00223	CcSEcCtD
Desogestrel—Dermatitis—Travoprost—glaucoma	0.00202	0.00223	CcSEcCtD
Desogestrel—Headache—Dorzolamide—glaucoma	0.00202	0.00223	CcSEcCtD
Desogestrel—Vomiting—Brinzolamide—glaucoma	0.00202	0.00222	CcSEcCtD
Desogestrel—Headache—Travoprost—glaucoma	0.00201	0.00222	CcSEcCtD
Desogestrel—Nausea—Brimonidine—glaucoma	0.00201	0.00221	CcSEcCtD
Desogestrel—Rash—Brinzolamide—glaucoma	0.002	0.00221	CcSEcCtD
Desogestrel—Dermatitis—Brinzolamide—glaucoma	0.002	0.0022	CcSEcCtD
Desogestrel—Gastrointestinal pain—Clonidine—glaucoma	0.00199	0.0022	CcSEcCtD
Desogestrel—Headache—Brinzolamide—glaucoma	0.00199	0.00219	CcSEcCtD
Desogestrel—Vomiting—Pilocarpine—glaucoma	0.00194	0.00214	CcSEcCtD
Desogestrel—Urticaria—Clonidine—glaucoma	0.00193	0.00213	CcSEcCtD
Desogestrel—Abdominal pain—Clonidine—glaucoma	0.00192	0.00212	CcSEcCtD
Desogestrel—Rash—Pilocarpine—glaucoma	0.00192	0.00212	CcSEcCtD
Desogestrel—Dermatitis—Pilocarpine—glaucoma	0.00192	0.00212	CcSEcCtD
Desogestrel—Nausea—Dorzolamide—glaucoma	0.00191	0.00211	CcSEcCtD
Desogestrel—Headache—Pilocarpine—glaucoma	0.00191	0.00211	CcSEcCtD
Desogestrel—Nausea—Travoprost—glaucoma	0.00191	0.0021	CcSEcCtD
Desogestrel—Nausea—Brinzolamide—glaucoma	0.00188	0.00208	CcSEcCtD
Desogestrel—Hypertension—Timolol—glaucoma	0.00183	0.00202	CcSEcCtD
Desogestrel—Gastrointestinal disorder—Betaxolol—glaucoma	0.00183	0.00202	CcSEcCtD
Desogestrel—Nausea—Pilocarpine—glaucoma	0.00181	0.002	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.00181	0.0192	CbGpPWpGaD
Desogestrel—PGR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.0018	0.0191	CbGpPWpGaD
Desogestrel—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00179	0.00198	CcSEcCtD
Desogestrel—Hypersensitivity—Clonidine—glaucoma	0.00179	0.00198	CcSEcCtD
Desogestrel—Nervous system disorder—Timolol—glaucoma	0.0017	0.00187	CcSEcCtD
Desogestrel—Urticaria—Betaxolol—glaucoma	0.00168	0.00186	CcSEcCtD
Desogestrel—Skin disorder—Timolol—glaucoma	0.00168	0.00186	CcSEcCtD
Desogestrel—Diarrhoea—Clonidine—glaucoma	0.00166	0.00184	CcSEcCtD
Desogestrel—Hypersensitivity—Betaxolol—glaucoma	0.00156	0.00172	CcSEcCtD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00155	0.0165	CbGpPWpGaD
Desogestrel—Vomiting—Clonidine—glaucoma	0.00155	0.00171	CcSEcCtD
Desogestrel—Rash—Clonidine—glaucoma	0.00153	0.00169	CcSEcCtD
Desogestrel—Dermatitis—Clonidine—glaucoma	0.00153	0.00169	CcSEcCtD
Desogestrel—Headache—Clonidine—glaucoma	0.00152	0.00168	CcSEcCtD
Desogestrel—PGR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.00151	0.016	CbGpPWpGaD
Desogestrel—Gastrointestinal disorder—Timolol—glaucoma	0.00149	0.00165	CcSEcCtD
Desogestrel—ESR1—ATF-2 transcription factor network—TGFB2—glaucoma	0.00149	0.0159	CbGpPWpGaD
Desogestrel—Diarrhoea—Betaxolol—glaucoma	0.00145	0.0016	CcSEcCtD
Desogestrel—PGR—Cellular roles of Anthrax toxin—TNF—glaucoma	0.00145	0.0154	CbGpPWpGaD
Desogestrel—Nausea—Clonidine—glaucoma	0.00145	0.0016	CcSEcCtD
Desogestrel—PGR—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.00143	0.0152	CbGpPWpGaD
Desogestrel—ESR1—FOXA1 transcription factor network—SOD1—glaucoma	0.00143	0.0152	CbGpPWpGaD
Desogestrel—Gastrointestinal pain—Timolol—glaucoma	0.00141	0.00156	CcSEcCtD
Desogestrel—Urticaria—Timolol—glaucoma	0.00137	0.00152	CcSEcCtD
Desogestrel—Abdominal pain—Timolol—glaucoma	0.00137	0.00151	CcSEcCtD
Desogestrel—Vomiting—Betaxolol—glaucoma	0.00135	0.00149	CcSEcCtD
Desogestrel—Rash—Betaxolol—glaucoma	0.00134	0.00147	CcSEcCtD
Desogestrel—ESR1—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.00133	0.0142	CbGpPWpGaD
Desogestrel—ESR1—Nuclear Receptors—NR3C1—glaucoma	0.00133	0.0142	CbGpPWpGaD
Desogestrel—Dermatitis—Betaxolol—glaucoma	0.00133	0.00147	CcSEcCtD
Desogestrel—Headache—Betaxolol—glaucoma	0.00133	0.00146	CcSEcCtD
Desogestrel—Hypersensitivity—Timolol—glaucoma	0.00127	0.00141	CcSEcCtD
Desogestrel—Nausea—Betaxolol—glaucoma	0.00126	0.00139	CcSEcCtD
Desogestrel—Diarrhoea—Timolol—glaucoma	0.00118	0.00131	CcSEcCtD
Desogestrel—Vomiting—Timolol—glaucoma	0.0011	0.00121	CcSEcCtD
Desogestrel—Rash—Timolol—glaucoma	0.00109	0.0012	CcSEcCtD
Desogestrel—Dermatitis—Timolol—glaucoma	0.00109	0.0012	CcSEcCtD
Desogestrel—Headache—Timolol—glaucoma	0.00108	0.0012	CcSEcCtD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.00106	0.0113	CbGpPWpGaD
Desogestrel—ESR1—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00105	0.0112	CbGpPWpGaD
Desogestrel—Nausea—Timolol—glaucoma	0.00103	0.00113	CcSEcCtD
Desogestrel—ESR1—AP-1 transcription factor network—EDN1—glaucoma	0.000895	0.00952	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.000893	0.0095	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—MMP2—glaucoma	0.000876	0.00932	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000869	0.00924	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000858	0.00913	CbGpPWpGaD
Desogestrel—ESR1—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.00084	0.00893	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.000837	0.0089	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.00083	0.00883	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.000819	0.00871	CbGpPWpGaD
Desogestrel—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.000803	0.00854	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.000752	0.008	CbGpPWpGaD
Desogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000729	0.00775	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.000708	0.00753	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000698	0.00742	CbGpPWpGaD
Desogestrel—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000685	0.00728	CbGpPWpGaD
Desogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000671	0.00714	CbGpPWpGaD
Desogestrel—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.000668	0.0071	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000661	0.00703	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—BAD—glaucoma	0.000642	0.00683	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—BAD—glaucoma	0.000622	0.00661	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000608	0.00647	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.00055	0.00585	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000534	0.00567	CbGpPWpGaD
Desogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000517	0.0055	CbGpPWpGaD
Desogestrel—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.000516	0.00549	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—LRP12—glaucoma	0.000512	0.00545	CbGpPWpGaD
Desogestrel—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.000484	0.00514	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000472	0.00502	CbGpPWpGaD
Desogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000471	0.00501	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000454	0.00482	CbGpPWpGaD
Desogestrel—ESR1—LKB1 signaling events—TP53—glaucoma	0.000438	0.00466	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000438	0.00465	CbGpPWpGaD
Desogestrel—PGR—Signaling by ERBB4—CDKN1B—glaucoma	0.000433	0.0046	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000418	0.00444	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000415	0.00441	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000407	0.00432	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000367	0.0039	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—BAD—glaucoma	0.000365	0.00388	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000355	0.00378	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—OPN4—glaucoma	0.000355	0.00377	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000354	0.00376	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HEYL—glaucoma	0.00033	0.00351	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—PTGFR—glaucoma	0.00032	0.0034	CbGpPWpGaD
Desogestrel—PGR—Generic Transcription Pathway—NR3C1—glaucoma	0.00031	0.0033	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000304	0.00323	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—LRP12—glaucoma	0.000301	0.0032	CbGpPWpGaD
Desogestrel—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.000297	0.00316	CbGpPWpGaD
Desogestrel—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	0.000254	0.0027	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—RPTOR—glaucoma	0.00025	0.00266	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NCK2—glaucoma	0.000242	0.00258	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000223	0.00238	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000212	0.00226	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000212	0.00225	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—OPN4—glaucoma	0.000208	0.00222	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	0.000208	0.00221	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—HDAC9—glaucoma	0.000206	0.00219	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HEYL—glaucoma	0.000194	0.00206	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—PTGFR—glaucoma	0.000188	0.00199	CbGpPWpGaD
Desogestrel—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	0.000182	0.00194	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000176	0.00187	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—CDKN2B—glaucoma	0.00017	0.00181	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—SMO—glaucoma	0.000161	0.00171	CbGpPWpGaD
Desogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000161	0.00171	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000151	0.0016	CbGpPWpGaD
Desogestrel—PGR—Gene Expression—NR3C1—glaucoma	0.000149	0.00159	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NTRK2—glaucoma	0.000147	0.00157	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—RPTOR—glaucoma	0.000147	0.00156	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NCK2—glaucoma	0.000142	0.00151	CbGpPWpGaD
Desogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000133	0.00141	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NGFR—glaucoma	0.000126	0.00134	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—HDAC9—glaucoma	0.000121	0.00129	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NTRK1—glaucoma	0.00012	0.00128	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN2B—glaucoma	0.000111	0.00118	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—EDN1—glaucoma	0.000106	0.00113	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—CDKN2B—glaucoma	0.0001	0.00106	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NGF—glaucoma	9.76e-05	0.00104	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—SMO—glaucoma	9.46e-05	0.00101	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—C3—glaucoma	9.28e-05	0.000987	CbGpPWpGaD
Desogestrel—ESR1—Gene Expression—NR3C1—glaucoma	8.77e-05	0.000933	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NTRK2—glaucoma	8.65e-05	0.00092	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—APOE—glaucoma	8.64e-05	0.000919	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CAV1—glaucoma	8.56e-05	0.00091	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—FN1—glaucoma	8.15e-05	0.000866	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—BAD—glaucoma	8.05e-05	0.000856	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NGFR—glaucoma	7.42e-05	0.000789	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NTRK1—glaucoma	7.05e-05	0.00075	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN2B—glaucoma	6.5e-05	0.000691	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—NOS3—glaucoma	6.47e-05	0.000688	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—EDN1—glaucoma	6.24e-05	0.000663	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NGF—glaucoma	5.73e-05	0.000609	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—CDKN1B—glaucoma	5.61e-05	0.000596	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—C3—glaucoma	5.45e-05	0.000579	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—MMP9—glaucoma	5.19e-05	0.000552	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—APOE—glaucoma	5.07e-05	0.000539	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CAV1—glaucoma	5.03e-05	0.000534	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—FN1—glaucoma	4.78e-05	0.000509	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—BAD—glaucoma	4.73e-05	0.000502	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—VEGFA—glaucoma	4.66e-05	0.000496	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—NOS3—glaucoma	3.8e-05	0.000404	CbGpPWpGaD
Desogestrel—PGR—Signaling Pathways—TP53—glaucoma	3.52e-05	0.000375	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—CDKN1B—glaucoma	3.29e-05	0.00035	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—MMP9—glaucoma	3.05e-05	0.000324	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—VEGFA—glaucoma	2.74e-05	0.000291	CbGpPWpGaD
Desogestrel—ESR1—Signaling Pathways—TP53—glaucoma	2.07e-05	0.00022	CbGpPWpGaD
